Pub. Date : 2020
PMID : 32547491
9 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | These endocrine-disrupting effects of BPA at the estrogen receptor (ER) occur despite the very low affinity of BPA for the ERbeta, which is 10,000 times lower than that of 17-beta estradiol, and despite the European regulatory authorities stating that BPA is safe, at usual exposure concentrations, the use of BPA in baby drink bottles was banned in 2011. | bisphenol A | estrogen receptor 1 | Homo sapiens |
2 | These endocrine-disrupting effects of BPA at the estrogen receptor (ER) occur despite the very low affinity of BPA for the ERbeta, which is 10,000 times lower than that of 17-beta estradiol, and despite the European regulatory authorities stating that BPA is safe, at usual exposure concentrations, the use of BPA in baby drink bottles was banned in 2011. | bisphenol A | estrogen receptor 1 | Homo sapiens |
3 | These endocrine-disrupting effects of BPA at the estrogen receptor (ER) occur despite the very low affinity of BPA for the ERbeta, which is 10,000 times lower than that of 17-beta estradiol, and despite the European regulatory authorities stating that BPA is safe, at usual exposure concentrations, the use of BPA in baby drink bottles was banned in 2011. | bisphenol A | estrogen receptor 1 | Homo sapiens |
4 | These endocrine-disrupting effects of BPA at the estrogen receptor (ER) occur despite the very low affinity of BPA for the ERbeta, which is 10,000 times lower than that of 17-beta estradiol, and despite the European regulatory authorities stating that BPA is safe, at usual exposure concentrations, the use of BPA in baby drink bottles was banned in 2011. | bisphenol A | estrogen receptor 1 | Homo sapiens |
5 | These endocrine-disrupting effects of BPA at the estrogen receptor (ER) occur despite the very low affinity of BPA for the ERbeta, which is 10,000 times lower than that of 17-beta estradiol, and despite the European regulatory authorities stating that BPA is safe, at usual exposure concentrations, the use of BPA in baby drink bottles was banned in 2011. | bisphenol A | estrogen receptor 1 | Homo sapiens |
6 | These endocrine-disrupting effects of BPA at the estrogen receptor (ER) occur despite the very low affinity of BPA for the ERbeta, which is 10,000 times lower than that of 17-beta estradiol, and despite the European regulatory authorities stating that BPA is safe, at usual exposure concentrations, the use of BPA in baby drink bottles was banned in 2011. | bisphenol A | estrogen receptor 1 | Homo sapiens |
7 | These endocrine-disrupting effects of BPA at the estrogen receptor (ER) occur despite the very low affinity of BPA for the ERbeta, which is 10,000 times lower than that of 17-beta estradiol, and despite the European regulatory authorities stating that BPA is safe, at usual exposure concentrations, the use of BPA in baby drink bottles was banned in 2011. | bisphenol A | estrogen receptor 1 | Homo sapiens |
8 | These endocrine-disrupting effects of BPA at the estrogen receptor (ER) occur despite the very low affinity of BPA for the ERbeta, which is 10,000 times lower than that of 17-beta estradiol, and despite the European regulatory authorities stating that BPA is safe, at usual exposure concentrations, the use of BPA in baby drink bottles was banned in 2011. | bisphenol A | estrogen receptor 1 | Homo sapiens |
9 | These endocrine-disrupting effects of BPA at the estrogen receptor (ER) occur despite the very low affinity of BPA for the ERbeta, which is 10,000 times lower than that of 17-beta estradiol, and despite the European regulatory authorities stating that BPA is safe, at usual exposure concentrations, the use of BPA in baby drink bottles was banned in 2011. | bisphenol A | estrogen receptor 1 | Homo sapiens |